Age-Related Macular Degeneration (AMD)
Age-related macular degeneration (AMD) stands as the leading cause of vision loss among older adults. It primarily impacts the retina, the delicate layer of light-sensitive tissue at the back of the eye. As people age, the macula, the central section of the retina responsible for sharp vision necessary for tasks like reading, driving, and recognizing faces, can deteriorate, leading to AMD.
While there is currently no cure for AMD, various promising treatments and active clinical trials are underway. At Montana Retina Consultants, we utilize advanced technology and individualized care to help slow down or halt the progression of AMD.
Types of AMD: Dry and Wet
Dry AMD is the most common form and can affect one or both eyes. In its early stages, symptoms may not be noticeable; however, as it progresses, individuals may experience increased blurriness, distortions in vision, and a reduced ability to perceive colors. Dry AMD has three stages: early, intermediate, and late (advanced).
In about 10% of cases, dry AMD can progress to wet AMD. Although less common, wet AMD is typically more severe and is considered an advanced stage of the disease. It occurs when abnormal blood vessels develop in the retina, causing them to leak blood or fluid into the macula. This leakage can potentially lead to permanent vision loss.
Geographic Atrophy
Geographic atrophy (GA) is a progressive form of dry AMD. This condition is characterized by atrophic lesions that initially develop in the outer retina and gradually expand to include the macula and the fovea. Vision loss due to geographic atrophy is permanent, underscoring the importance of early detection and management.
Who’s at Risk for Developing AMD?
The leading cause of AMD is the natural aging process of the eye, most commonly affecting individuals over the age of 50. Other risk factors include:
Genetic predisposition or family history
Smoking
High blood pressure
High cholesterol
Diabetes
Obesity
Poor diet
AMD Symptoms
AMD often doesn't show symptoms in its early stages. As the condition advances, individuals may experience:
Blurred central vision
Difficulty seeing in low light
Changes in color perception
Dark or blank spots in the field of vision
Straight lines appearing curvy or wavy
Challenges with reading, driving, or seeing fine details
Diagnosing AMD
During an eye exam, your physician will check for signs of AMD, one of which is the presence of drusen. Drusen are yellow or white fatty protein deposits that build up beneath the retina. While it’s typical for older adults to have small amounts of drusen, a greater quantity may suggest the onset of AMD. The size and number of these deposits can also help retina specialists in identifying the stage of the disease.
Other diagnostic tools include:
Eye dilation: During an eye exam, the doctor will apply special drops to widen the pupil, allowing for a more thorough examination of the retina.
Optical coherence tomography (OCT): This non-invasive scan uses infrared light to capture cross-sectional retinal images.
Fluorescein angiography: A fluorescent dye is injected into the arm to illuminate the blood vessels in the retina and reveal any leakage.
Indocyanine green angiography: This test uses a dye that responds to infrared light, making it easier for a retina specialist to see the deeper blood vessels in the retina.
Amsler grid test: The Amsler grid is a simple square containing a grid pattern and a dot in the middle that can help identify problem areas in the field of vision.
Treating AMD
Treatment of dry macular degeneration includes vitamin supplementation (AREDS2 formula) to prevent progression of the disease in patients with moderate to high risk characteristics. The Age-Related Eye Disease Studies (from which the AREDS formula gets its name) found that vitamins reduce the rate of progression of AMD from around 30% over the course of five years to about 20%. The currently recommended formula is the AREDS2 formula, from the latest version of the study.
Wet Macular Degeneration
Treatment for wet macular degeneration has improved dramatically over the last 15 years. The key to effective treatment is early detection, especially with Amsler grid monitoring daily and regular eye exams. If you notice any change in your vision or distortion, you should see a retina specialist within 2-3 days of the onset of a change.
Anti-VEGF Medications
The most common treatment for wet AMD involves injecting anti-vascular endothelial growth factor (VEGF) drugs into the eye. These medications target the chemical responsible for abnormal blood vessel formation under the retina. Anti-VEGF treatment aims to preserve vision while minimizing the frequency of injections. Treatments are tailored to each individual based on their response.
Excitingly, our treatment options continue to evolve. If one medication proves ineffective, there are two additional options available. Most patients respond positively to at least one of these medications, with about 90% showing good responses across all three.
Patients often experience anxiety about the injection process, but with appropriate topical anesthesia, the procedure is generally painless; many do not even notice the injection occurring. Some discomfort may arise afterward due to the sterilizing solution used, and we recommend using artificial tears or ointment for relief. Patients are encouraged to resume normal activities as soon as they feel comfortable.
Low Vision Therapy
Once your condition is stabilized, you may be a candidate for low vision aids. In those patients who are having difficulty with their central vision, these aids can greatly enhance your visual functioning. Our staff can make the appropriate referral to a low vision expert upon the doctor’s recommendation.
Schedule an Age-Related Macular Degeneration Consultation Today
At Montana Retina Consultants, our team of experienced retina specialists can diagnose and treat the full spectrum of retinal conditions, including AMD. Request an appointment today at our retina center in Bozeman.